Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

75 resultsUpdated October 29, 2026
1

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

Computational and Structural Biotechnology Journal 18 (2020)

Bo Ram Beck; Bonggun Shin; Yoonjung Choi; Sung‐Soo Park; Keunsoo Kang

5

Current pharmacological treatments for COVID‐19: What's next?

British Journal of Pharmacology 177(21) (2020)

Cristina Scavone; Simona Brusco; Michele Bertini; Liberata Sportiello; Concetta Rafaniello; Alice Zoccoli; Liberato Berrino; Giorgio Racagni; Francesco Rossi; Annalisa Capuano

6

Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study

Informatics in Medicine Unlocked 19 (2020)

Karlapudi Abraham Peele; Chandrasai Potla Durthi; T. Srihansa; S. Krupanidhi; Vijaya Sai Ayyagari; D. John Babu; M. Indira; Aluru Ranganadha Reddy; Thirupati Chinna Venkateswarulu

8

Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

International Journal of Molecular Sciences 21(9) (2020)

Maria Bzówka; Karolina Mitusińska; Agata Raczyńska; Aleksandra Samol; Jack A. Tuszyński; Artur Góra

9

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment

Journal of the International AIDS Society 23(4) (2020)

Nathan Paul Ford; Marco Vitória; Ajay Rangaraj; Susan L. Norris; Alexandra Calmy; Meg C. Doherty

10

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)

Frontiers in Pharmacology 11 (2020)

Surjeet Verma; Danielle Twilley; Tenille Esmear; Carel B. Oosthuizen; Anna-Mari Reid; Marizé Cuyler; Namrita Lall

11

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India

The Indian Journal of Medical Research 151(2-3) (2020)

Tarun Bhatnagar; Manoj Vasanth Murhekar; Manish Soneja; Nivedita Gupta; Sidhartha Giri; Naveet Wig; Raman Gangakhedkar

13

Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses

Molecules 25(8) (2020)

Nakarin Suwannarach; Jaturong Kumla; Kanaporn Sujarit; Thanawat Pattananandecha; Chalermpong Saenjum; Saisamorn Lumyong

14

Classification, structure and mechanism of antiviral polysaccharides derived from edible and medicinal fungus

International Journal of Biological Macromolecules 183 (2021)

Yuxi Guo; Xuefeng Chen; Pin Gong

15

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach

Indian Journal of Pharmacology 52(1) (2020)

Bikash Medhi; Phulen Sarma; Manisha Prajapat; Pramod Avti; Hardeep Kaur; Subodh Kumar

16

Emerging prophylaxis strategies against COVID-19

Monaldi Archives for Chest Disease 90(1) (2020)

Sumita Pravesh Agrawal; Akhil Dhanesh Goel; Nitesh Gupta

17

Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report

American Journal of Transplantation 20(7) (2020)

Ling Gui Ning; Lei Liu; Wenyuan Li; Hongtao Liu; Jizhou Wang; Ziqin Yao; Shengyu Zhang; Desheng Zhao; Björn Nashan; Aizong Shen; Lianxin Liu; Lei Li

18

Therapeutic opportunities of edible antiviral plants for COVID-19

Molecular and Cellular Biochemistry 476(6) (2021)

Bhoomika M. Patel; Supriya Sharma; Nisha Nair; Jaseela Majeed; Ramesh Kishorilal Goyal; Mahaveer Dhobi

20

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

RSC Advances 10(45) (2020)

Gamal El‐Din A. Abuo‐Rahma; Mamdouh F. A. Mohamed; Tarek Salah Ibrahim; Mai E. Shoman; Ebtihal Samir; Rehab Mahmoud Abd El-Baky

21

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening

Journal of Clinical Medicine 9(7) (2020)

Cristina Adriana Dehelean; Voichița Elena Lăzureanu; Dorina Elena Coricovac; Marius Mioc; Roxana Oancea; Iasmina Marcovici; Iulia Pînzaru; Codruţa Şoica; Aristidis Michael Tsatsakis; Octavian Marius Cretu

22

Vaccines and Therapies in Development for SARS-CoV-2 Infections

Journal of Clinical Medicine 9(6) (2020)

David Bin-Chia Wu; Raghuram Koganti; Upendra Pradeep Lambe; Tejabhiram Yadavalli; Shyam Sundar Nandi; Deepak Shukla

23

Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis

Pharmaceuticals 14(4) (2021)

Magdi E. A. Zaki; Sami A. Al‐Hussain; Vijay Hariram Masand; Siddhartha Akasapu; Sumit O. Bajaj; Nahed N. E. El-Sayed; Arabinda Ghosh; Israa Lewaa

24

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development

Journal of Gynecology Obstetrics and Human Reproduction 49(10) (2020)

Guilherme Antonio de Souza Silva; Suéllen Pedrosa da Silva; Marcos Aurélio Santos da Costa; Abdênego Rodrigues da Silva; Robson Raion de Vasconcelos Alves; Fernanda das Chagas Ângelo Mendes Tenório; Alanne Rayssa da Silva Melo; Antônio Carlos de Freitas; Cristiane Moutinho Lagos de Melo

25

Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery

Current Drug Research Reviews 13(2) (2021)

Supriya Roy; Suneela Sunil Dhaneshwar; Bhavya Bhasin

26
27
28

Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study

Journal of Biomolecular Structure and Dynamics 40(12) (2021)

Vanderlan Nogueira Holanda; Elton Marlon de Araújo Lima; Welson Vicente da Silva; Rafael Trindade Maia; Rafael de Lima. MEDEIROS; Arabinda Ghosh; Vera Lúcia de Menezes Lima; Regina Célia Bressan Queiroz de Figueiredo

29

An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia

PLoS ONE 16(6) (2021)

Purwati Purwati; Andang Miatmoko; Nasronudin Nasronudin; Eryk Hendrianto; Deya Karsari; Aristika Dinaryanti; Nora Ertanti; Igo Syaiful Ihsan; Disca Sandyakala Purnama; Tri Pudy Asmarawati; Erika Marfiani; Yulistiani Yulistiani; Alfian Nur Rosyid; Prastuti Asta Wulaningrum; Herley Windo Setiawan; Imam Siswanto; Ni Nyoman Tri Puspaningsih

30

Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2

Molecular Biology and Evolution 38(2) (2020)

Erica Teixeira Prates; Michael R. Garvin; Mirko Pavicic; Piet C. Jones; Manesh B. Shah; Omar Demerdash; B Kirtley Amos; Armin Geiger; Daniel Jacobson

31

COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach

Drug Design Development and Therapy Volume 15 (2021)

Soha R. Abd El Hadi; Esmat E Zien El-Deen; Mostafa M. Bahaa; Abdelfattah A. Sadakah; Heba Yassin

32

Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction

Virology 604 (2025)

Ankita Saha; Shweta Choudhary; Priyanshu Walia; Pravindra Kumar; Shailly Tomar

33

In Silico Investigation of the SARS CoV2 Protease with Thymoquinone, the Major Constituent of Nigella Sativa

Current Drug Discovery Technologies 18(4) (2020)

Youness Kadil; Mohammed Mouhcine; Houda Filali

34

Safety perspectives on presently considered drugs for the treatment of COVID‐19

British Journal of Pharmacology 177(19) (2020)

Sophie L. Penman; Robyn T. Kiy; Rebecca L. Jensen; Christopher Beoku Betts; Ana Alfirevic; David J. Back; Saye Khoo; Andrew Owen; Munir Pirmohamed; B. Kevin Park; Xiaoli Meng; Christopher E. Goldring; Amy E. Chadwick

36

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective

Journal of Pharmaceutical Sciences 110(3) (2020)

Simone Perazzolo; Linxi Zhu; Weixian Lin; Alexander Nguyen; Rodney J. Y. Ho

37

In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19

In Silico Pharmacology 9(1) (2021)

Peter Ifeoluwa Adegbola; Olumide Samuel Fadahunsi; Aanuoluwa Eunice Adegbola; Banjo Semire

38

A multiple peptides vaccine against COVID-19 designed from the nucleocapsid phosphoprotein (N) and Spike Glycoprotein (S) via the immunoinformatics approach

Informatics in Medicine Unlocked 21 (2020)

Sahar Obi Abd Albagi; Mosab Yahya Al-Nour; Mustafa Elhag; Asaad Tageldein Idris Abdelhalim; Esraa Musa Haroun; Mohammed Elmujtba Adam Essa; Mustafa Abubaker; Hemchandra Deka; Arabinda Ghosh; Mohammed A. Hassan

39

COVID-19: только научные факты

Dalʹnevostočnyj medicinskij žurnal(1) (2020)

40

RETRACTED ARTICLE: A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort

European Journal of Clinical Microbiology & Infectious Diseases 40(2) (2020)

Yasemin Çağ; Sacit İçten; Burcu Isık Goren; Naciye Betül Baysal; Begüm Bektaş; Ece Selvi; Pınar Ergen; Özlem Aydın; Ayşe Canan Üçışık; Fatma Yılmaz Karadağ; Hülya Çaşkurlu; Tülin Akarsu Ayazoğlu; Hasan Koçoğlu; Sinan Uzman; Muge Nural-Pamukcu; Ferhat Arslan; Gürhan Baş; Mahmut Tayyar Kalcioglu; Haluk Vahaboğlu

41

Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study

Journal of Physics Conference Series 1797(1) (2021)

Tanmoy Dutta; Sajal Ghorai; Abdul Ashik Khan; Nabajyoti Baildya; Narendra Nath Ghosh

42

CAUSES OF DEATH AMONG MUSCOVITES BEFORE AND DURING THE COVID-19 PANDEMIC

Social Aspects of Population Health 66(4) (2020)

Tamara P. Sabgayda; Alla Ivanova; Sergey G. Rudnev; Victoria G. Semyonova

43

COVID-19 and HIV/AIDS in a cohort study in Sao Paulo, Brazil: outcomes and disparities by race and schooling

AIDS Care 34(7) (2021)

S. Q. Rocha; Vivian Iida Avelino‐Silva; Mariza Vono Tancredi; L. Jamal; Paulo Roberto Abrão Ferreira; Ângela Tayra; Patrícia Marques Ferreira; Telma Regina Marques Pinto Carvalhanas; Carmen Silvia Bruniera Domingues; Rita Adriana Gomes de Souza; Maria Clara Gianna; Artur Olhovetchi Kalichman; O. H. M. Leite; Tâmara Newman Lobato Souza; D. A. Gomes e Costa; Juvêncio José Duailibe Furtado; Angelo Costa; for the HIV-COVID/SP Study Group

44

Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights

Biophysical Reviews 17(2) (2025)

Fernando Luís Barroso da Silva; Karen Paco; Aatto Laaksonen; Animesh Ray

45

COVID-19: a wreak havoc across the globe

Archives of Physiology and Biochemistry 129(1) (2020)

Heena Rehman; Md Iftekhar Ahmad

46

Computational modeling of the pharmacological actions of some antiviral agents against SARS-CoV-2

Elsevier eBooks (2021)

Abayomi Emmanuel Adegboyega; Titilayo Omolara Johnson; Simeon Omale

48

Therapeutic approaches to coronavirus infection according to “One Health” concept

Research in Veterinary Science 136 (2021)

Giacomo Rossi; Livio Galosi; Alessandra Gavazza; Matteo Cerquetella; Sara Mangiaterra

49

The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course

Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology 15(1) (2021)

Н. В. Бобкова

50

Targeting COVID-19 pandemic: in silico evaluation of 2-hydroxy-1, 2-diphenylethanone N(4)-methyl-N(4)-phenylthiosemicarbazone as a potential inhibitor of SARS-CoV-2

Structural Chemistry 34(5) (2022)

Rajan Jeevana; Abu Pilakkaveettil Kavitha; T. G. Abi; Pookkottu K. Sajith; Jibin K. Varughese; Kuttamath Kunniyur Aravindakshan

51

Integrating LC–MS/MS and In Silico Methods to Uncover Bioactive Compounds with Lipase Inhibitory Potential in the Antarctic Moss Warnstorfia fontinaliopsis

Applied Biochemistry and Biotechnology 197(4) (2025)

Hirotake Yamaguchi; Ryoichi Yamada; Kristina Lama; Ui Joung Youn; Jun Hyuck Lee; Tae‐Jin Oh

53

Natural Products as Anti-COVID-19 Agents: An In Silico Study

Coronaviruses 2(5) (2020)

Chandan Kumar Sarkar; Sarmin Jamaddar; Milon Mondal; Abul Bashar Ripon Khalipha; Muhammad Torequl Islam; Mohammad Suleiman Mubarak

54

FDA recommended potent drugs against COVID-19: Insight through molecular docking

Materials Today Proceedings 45 (2021)

Khushbu Gumber; Pomila

55

An update on COVID-19 outbreak: The longest pandemic

Biological Sciences 02(01) (2022)

Seema Mahor; Hina Chadha; Sarita Prajapati; Sudhanshu K. Mishra; Smriti Ojha

56

Drug Safety Issues in Therapy COVID-19

The Russian Archives of Internal Medicine 10(3) (2020)

D. G. Levitova; Svetlana Alexandrovna Gracheva; A. S. Samoylov; Ur.D. Udalov; Evgeniy A. Praskurnichiy; Oleg V. Parinov

57

A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review

Coronaviruses 2(7) (2020)

Sumel Ashique; Navjot Kaur Sandhu; Sk. Niyamul Haque; Kartick Koley

58

Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19

Mini-Reviews in Medicinal Chemistry 21(8) (2020)

Ekta Shirbhate; Preeti Patel; Vijay K. Patel; Ravichandran Veerasamy; Prabodh Chander Sharma; Barij Nayan Sinha; Harish Rajak

59

Remdesivir e lopinavir/ritonavir frente ao novo coronavírus: breve revisão

VITTALLE - Revista de Ciências da Saúde 32(1) (2020)

Lara Beatriz Ferreira; Daniela Fernandes Ramos

60

Covid-19 in Children: A Review of Manifestations and Treatment Options

The Anatolian Journal of Family Medicine (2020)

Olayinka Rasheed Ibrahim

61

Potential Dancer Resistance to Covid-19 Exposure

Proceedings of the International Seminar of Science and Applied Technology (ISSAT 2020) (2020)

Nurida Finahari; Gatut Rubiono

62

Finding a prospective dual-target drug for the treatment of coronavirus disease by theoretical study

Journal of Biomolecular Structure and Dynamics 40(23) (2021)

Karim Mahnam; Zahra Ghobadi

63

Potential antiviral therapies for coronavirus disease 2019 (COVID-19)

Elsevier eBooks (2022)

Jasdeep Singh; Divya Singhal

64

An Overview of COVID-19: Focus on Pharmacological Aspect

SBV Journal of Basic Clinical and Applied Health Science 3(2) (2020)

Nandhini Saravanabavan; Padmavathi Shanmuganathan; Manimekalai Kumarappan; Kartik Janardan Salwe; Barathane Datchanamurthy; J. Johan Pandian; R. Sudar Codi; Vimala Ananthy; Kamalasundar Thanuskodi; Uma Narayanamurthy

65

Control and therapeutics for covid-19

Indian Journal of Health Sciences and Care 7(2) (2020)

Shweta Sharma; Angelika Batta; Vinod Kapoor; Kapil Hazarika

67

COVID-19: CURRENT PHARMACOLOGICAL THERAPEUTIC APPROACHES

Universal Journal of Pharmaceutical Research (2021)

Mai El-Sayed Ghoneim; Asmaa A. Khalifa; Bassma M. Ali

68

COVID-19 pandemic: The deadly respiratory disease of 21st century

Current Research in Pharmaceutical Sciences 11(1) (2021)

Shweta Jain; Pankaj Kumar Jain; Ramakant Yadav; Surendra Jain; Ankur Vaidya

71

Computational Approaches for Lead Discovery against SARS-CoV-2 3C-Like Protease: Virtual Screening and Molecular Dynamics Studies

Journal of Medicine and Health Studies (2023)

Mohammad Kalim Ahmad Khan; Feras Almarshad

72

Probable selective compounds for inhibition of SARS-CoV-2 infection: A review

The Thai Journal of Pharmaceutical Sciences 45(5) (2021)

Nagaraju Rajendraprasad

74

Lipophilic Efficiency as an Important Metric in the Design of SARS coronavirus 3C-like proteinase (3CL-pro) Inhibitors: Guidepost towards Lead Selection and Optimization in the Treatment of COVID-19

ASRIC Journal on Health Sciences 1(1) (2021)

George Oche Ambrose; Joseph Igbo Enya; Tamonokorite AbelJack-Soala; Bukola Temitope Fabunmi; Ajayi Kolawole Temidayo; Bankole Olukayode Olusola